로딩 중…
StockDiggingStockDigging

조아제약

034940· KOSDAQ
₩507-13.63%
2026-06-19

Price Chart

조아제약-50.34%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap15.71B KRW
Revenue59.62B KRW
Net Income-5.31B KRW
Total Assets63.04B KRW
Net Assets21.62B KRW
Employees279
Value
P/B0.73x
P/S0.26x
FCF Yield-33.64%
Profitability
ROE-24.56%
ROA-8.42%
Op. Margin-9.41%
Revenue Growth2.15%
Financial Health
Debt Ratio291.59%
Total Debt24.97B KRW
FCF-5.28B KRW
Cash2.83B KRW
Current Ratio1.08x
Performance
1Y Return-50.34%
1M Return-37.71%
From 52W High-64.30%
1Y MDD-60.05%
Trading
Volume554,717 shares
Foreign Own.2.37%
Per Share
EPS-153 KRW
BPS808 KRW

Company Info

CEO 조성환, 조성배(각자대표)
Employees 279
Founded 1996
HQ 서울특별시 영등포구, KR

Joa Pharmaceutical, established in 1996, was formed following the acquisition of Samgang Pharmaceutical Company in 1988. It operates the pharmacy franchise Medipharm as a subsidiary. The company produces and supplies over 200 pharmaceuticals and health foods, including Hepatos and Evathion, supported by over 100 Medical Representatives across 15 nationwide sales offices. Since beginning exports to Vietnam in 1995, Joa Pharmaceutical now exports over 150 product types to 23 countries, striving to become a global healthcare leader through innovative product development and brand competitiveness. Joa Pharmaceutical is headquartered in Yeongdeungpo-gu, Seoul Metropolitan City.